Literature DB >> 15194531

Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.

Wilma Barcellini1, Elisa Fermo, Francesca Guia Imperiali, Anna Zaninoni, Paola Bianchi, Carla Boschetti, Alberto Zanella.   

Abstract

BACKGROUND AND OBJECTIVES: Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal disorder due to a PIG-A gene mutation, resulting in deficient expression of GPI-anchored-proteins. Both immune-mediated suppression of hematopoiesis and cytokine alterations have been reported in aplastic anemia, a disease closely related to PNH whereas no data are available on PNH itself. The aim of this study was to investigate the effect of exogenous cytokines on clonogenic activity in PNH. DESIGN AND METHODS: We evaluated burst-forming units-erythroid (BFU-E) and colony-forming units-granulocyte-macrophage (CFU-GM) in bone marrow mononuclear cells (BMMC) from 5 PNH patients and 5 controls, alone or in the presence of transforming-growth-factor (TGF)-beta, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, and specific antibodies. Molecular analysis of the PIG-A gene was performed by polymerase chain reaction (PCR) and direct sequencing on every single colony.
RESULTS: Patients' cells showed less clonogenic activity than did control cells. In PNH, addition of TGF-beta inhibited both BFU-E and CFU-GM; IFN-gamma and TNF-alpha inhibited BFU-E alone. In patients cytokines modulated normal and mutated clones differently: TGF-b reduced the number of PIG-A- and PIG-A+ colony-forming-cells (CFC), whereas TNF-alpha and IFN-gamma reduced PIG-A+ CFC only. BMMC from patients showed higher TGF-beta production than did BMMC from controls. INTERPRETATION AND
CONCLUSIONS: TGF-beta could contribute to the genesis of the unfavorable bone marrow microenvironment but does not seem to play a role in the in vivo dominance of PIG-A deficient cells. Mutated clones were more resistant to the inhibitory effects of IFN-gamma and TNF-alpha, suggesting that PNH cells may have a growth advantage in an unfavorable microenvironment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194531

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  5 in total

Review 1.  Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria.

Authors:  Lucio Luzzatto; Giacomo Gianfaldoni
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

2.  EMS mutant spectra generated by multi-parameter flow cytometry.

Authors:  Stephen B Keysar; Michael H Fox
Journal:  Mutat Res       Date:  2009-05-20       Impact factor: 2.433

3.  Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.

Authors:  Sa A Wang; Olga Pozdnyakova; Jeffrey L Jorgensen; L Jeffrey Medeiros; Dariusz Stachurski; Mary Anderson; Azra Raza; Bruce A Woda
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

4.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases.

Authors:  Günter Müller
Journal:  Diabetes Metab Syndr Obes       Date:  2012-08-07       Impact factor: 3.168

Review 5.  Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Melissa A Colden; Sushant Kumar; Bolormaa Munkhbileg; Daria V Babushok
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.